114 related articles for article (PubMed ID: 18836304)
21. An autologous in situ tumor vaccination approach for hepatocellular carcinoma. 2. Tumor-specific immunity and cure after radio-inducible suicide gene therapy and systemic CD40-ligand and Flt3-ligand gene therapy in an orthotopic tumor model.
Kawashita Y; Deb NJ; Garg MK; Kabarriti R; Fan Z; Alfieri AA; Roy-Chowdhury J; Guha C
Radiat Res; 2014 Aug; 182(2):201-10. PubMed ID: 24992166
[TBL] [Abstract][Full Text] [Related]
22. [LASS2 interacts with V-ATPase and inhibits cell growth of hepatocellular carcinoma].
Tang N; Jin J; Deng Y; Ke RH; Shen QJ; Fan SH; Qin WX
Sheng Li Xue Bao; 2010 Jun; 62(3):196-202. PubMed ID: 20571735
[TBL] [Abstract][Full Text] [Related]
23. Regulatory proteins of F1F0-ATPase: role of ATPase inhibitor.
Hashimoto T; Yoshida Y; Tagawa K
J Bioenerg Biomembr; 1990 Feb; 22(1):27-38. PubMed ID: 2140357
[TBL] [Abstract][Full Text] [Related]
24. The structural and functional connection between the catalytic and proton translocating sectors of the mitochondrial F1F0-ATP synthase.
Papa S; Zanotti F; Gaballo A
J Bioenerg Biomembr; 2000 Aug; 32(4):401-11. PubMed ID: 11768302
[TBL] [Abstract][Full Text] [Related]
25. Antiangiogenic gene therapy for hepatocellular carcinoma using angiostatin gene.
Ishikawa H; Nakao K; Matsumoto K; Ichikawa T; Hamasaki K; Nakata K; Eguchi K
Hepatology; 2003 Mar; 37(3):696-704. PubMed ID: 12601367
[TBL] [Abstract][Full Text] [Related]
26. Antitumor activities of human autologous cytokine-induced killer (CIK) cells against hepatocellular carcinoma cells in vitro and in vivo.
Wang FS; Liu MX; Zhang B; Shi M; Lei ZY; Sun WB; Du QY; Chen JM
World J Gastroenterol; 2002 Jun; 8(3):464-8. PubMed ID: 12046071
[TBL] [Abstract][Full Text] [Related]
27. Subunit c from the sodium-ion-translocating F1F0-ATPase of Propionigenium modestum--production, purification and properties of the protein in dodecylsulfate solution.
Matthey U; Kaim G; Dimroth P
Eur J Biochem; 1997 Aug; 247(3):820-5. PubMed ID: 9288903
[TBL] [Abstract][Full Text] [Related]
28. The inhibitor protein (IF1) promotes dimerization of the mitochondrial F1F0-ATP synthase.
García JJ; Morales-Ríos E; Cortés-Hernandez P; Rodríguez-Zavala JS
Biochemistry; 2006 Oct; 45(42):12695-703. PubMed ID: 17042487
[TBL] [Abstract][Full Text] [Related]
29. Effects of a novel immunomodulating agent, FTY720, on tumor growth and angiogenesis in hepatocellular carcinoma.
Ho JW; Man K; Sun CK; Lee TK; Poon RT; Fan ST
Mol Cancer Ther; 2005 Sep; 4(9):1430-8. PubMed ID: 16170036
[TBL] [Abstract][Full Text] [Related]
30. Purification and properties of the F1F0 ATPase of Ilyobacter tartaricus, a sodium ion pump.
Neumann S; Matthey U; Kaim G; Dimroth P
J Bacteriol; 1998 Jul; 180(13):3312-6. PubMed ID: 9642181
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the H(+)-pumping F1F0 ATPase of Vibrio alginolyticus.
Krumholz LR; Esser U; Simoni RD
J Bacteriol; 1990 Dec; 172(12):6809-17. PubMed ID: 2147679
[TBL] [Abstract][Full Text] [Related]
32. Reduction of tumorigenicity of SMMC-7721 hepatoma cells by vascular endothelial growth factor antisense gene therapy.
Tang YC; Li Y; Qian GX
World J Gastroenterol; 2001 Feb; 7(1):22-7. PubMed ID: 11819727
[TBL] [Abstract][Full Text] [Related]
33. The asialoglycoprotein receptor suppresses the metastasis of hepatocellular carcinoma via LASS2-mediated inhibition of V-ATPase activity.
Gu D; Jin H; Jin G; Wang C; Wang N; Hu F; Luo Q; Chu W; Yao M; Qin W
Cancer Lett; 2016 Aug; 379(1):107-16. PubMed ID: 27241665
[TBL] [Abstract][Full Text] [Related]
34. Antibody mediated therapy targeting CD47 inhibits tumor progression of hepatocellular carcinoma.
Xiao Z; Chung H; Banan B; Manning PT; Ott KC; Lin S; Capoccia BJ; Subramanian V; Hiebsch RR; Upadhya GA; Mohanakumar T; Frazier WA; Lin Y; Chapman WC
Cancer Lett; 2015 May; 360(2):302-9. PubMed ID: 25721088
[TBL] [Abstract][Full Text] [Related]
35. The F1F0-ATPase complex from bovine heart mitochondria: the molar ratio of the subunits in the stalk region linking the F1 and F0 domains.
Collinson IR; Skehel JM; Fearnley IM; Runswick MJ; Walker JE
Biochemistry; 1996 Sep; 35(38):12640-6. PubMed ID: 8823202
[TBL] [Abstract][Full Text] [Related]
36. A double mutation in subunit c of the Na(+)-specific F1F0-ATPase of Propionigenium modestum results in a switch from Na+ to H(+)-coupled ATP synthesis in the Escherichia coli host cells.
Kaim G; Dimroth P
J Mol Biol; 1995 Nov; 253(5):726-38. PubMed ID: 7473747
[TBL] [Abstract][Full Text] [Related]
37. Structure of the vacuolar adenosine triphosphatases.
Wilkens S
Cell Biochem Biophys; 2001; 34(2):191-208. PubMed ID: 11898864
[TBL] [Abstract][Full Text] [Related]
38. Targeting of hepatoma cell and suppression of tumor growth by a novel 12mer peptide fused to superantigen TSST-1.
Jiang YQ; Wang HR; Li HP; Hao HJ; Zheng YL; Gu J
Mol Med; 2006; 12(4-6):81-7. PubMed ID: 16953561
[TBL] [Abstract][Full Text] [Related]
39. Plasma Cell Polarization to the Immunoglobulin G Phenotype in Hepatocellular Carcinomas Involves Epigenetic Alterations and Promotes Hepatoma Progression in Mice.
Wei Y; Lao XM; Xiao X; Wang XY; Wu ZJ; Zeng QH; Wu CY; Wu RQ; Chen ZX; Zheng L; Li B; Kuang DM
Gastroenterology; 2019 May; 156(6):1890-1904.e16. PubMed ID: 30711627
[TBL] [Abstract][Full Text] [Related]
40. Evidence from immunological studies of structure-mechanism relationship of F1 and F1F0.
Gautheron DC; Godinot C
J Bioenerg Biomembr; 1988 Aug; 20(4):451-68. PubMed ID: 2464585
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
